id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1492-0003,FDA,FDA-2014-D-1492,"Two-Phased Chemistry, Manufacturing, and Controls Technical 
Sections; Draft Guidance for Industry; Extension of Comment Period",Notice,Extension of Comment Period,2014-12-09T05:00:00Z,2014,12,2014-12-09T05:00:00Z,2015-02-18T04:59:59Z,2015-03-19T02:12:12Z,2014-28713,0,0,0900006481967c1e
FDA-2014-D-1492-0002,FDA,FDA-2014-D-1492,"Draft Guidance for Industry on Two-Phased Chemistry, Manufacturing, and Controls (CMC) Technical Sections",Other,Guidance,2014-10-20T04:00:00Z,2014,10,2014-10-20T04:00:00Z,,2024-09-17T14:40:16Z,,0,0,09000064818de9c8
FDA-2014-D-1492-0001,FDA,FDA-2014-D-1492,"Two-Phased Chemistry, Manufacturing, and Controls Technical
Sections; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2014-10-20T04:00:00Z,2014,10,2014-10-20T04:00:00Z,2014-12-20T04:59:59Z,2015-03-13T02:02:02Z,2014-24796,0,0,09000064818dd7b4